A Phase I Study Of Oxaliplatin And Doxorubicin In Pediatric Patients With Relapsed Or Refractory Extracranial Non-Hematopoietic Solid Tumors

BACKGROUND: The combination of a platinum agent and anthracycline has shown activity in pediatric solid tumors. This trial evaluated the maximum tolerated dose (MTD) and dose limiting toxicities (DLT) of oxaliplatin combined with doxorubicin in pediatric patients with recurrent solid tumors. METHODS...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mascarenhas, Leo, Malogolowkin, Marcio, Armenian, Saro H., Sposto, Richard, Venkatramani, Rajkumar
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3815656/
https://ncbi.nlm.nih.gov/pubmed/23335436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24471
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky